News (USA)

Daily HIV medications might be replaced by bimonthly injections

Daily HIV medications might be replaced by bimonthly injections

The results of an 8-month study into injectable medication for HIV are out, and the news is good.

From GSK:

These results show that the investigational, long acting, injectable formulations of cabotegravir (ViiV Healthcare) and rilpivirine (Janssen) were comparable in maintaining viral suppression rates to a three drug oral regimen of investigational cabotegravir and two nucleoside reverse transcriptase inhibitors (NRTIs).

The language is a bit dense, but what it means is that long-lasting, injectable versions of the drugs were just as effective in fighting HIV as a daily dose in pill form. Injectable medication could be the next frontier in fighting HIV, since adherence to HIV meds is crucial to keeping the virus at bay.

Furthermore, the injectable drugs don’t need to be taken as frequently as pill doses:

Viral suppression rates (plasma HIV-1 RNA

We recommend that you read the entire release, but it’s definitely an exciting new development in the battle against HIV/AIDS.

And if you’re wondering about injectable PrEP, that’s another tool that looks like it’s on the way.

Don't forget to share:

Support vital LGBTQ+ journalism

Reader contributions help keep LGBTQ Nation free, so that queer people get the news they need, with stories that mainstream media often leaves out. Can you contribute today?

Cancel anytime · Proudly LGBTQ+ owned and operated

Italian Football President to gays: Stay away from me!

Previous article

Kentucky clerk Kim Davis loses latest gay marriage appeal

Next article